Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

908 Devices Inc. - Common Stock (NQ: MASS )

4.340 +0.020 (+0.47%)
Streaming Delayed Price Updated: 10:57 AM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about 908 Devices Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
3 Cathie Wood Stocks With Parabolic Growth Potential, According to Wall Street
These cutting-edge biotech stocks could deliver life-changing gains for early shareholders. 
Via The Motley Fool
12 Information Technology Stocks Moving In Tuesday's Intraday Session
Via Benzinga
908 Devices Reports Second Quarter 2023 Financial Results and Updates 2023 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
Earnings Preview: 908 Devices
Via Benzinga
908 Devices Partners with Tennessee State and Local Agencies in the Fight Against Drug Trafficking Through a New Pilot Program
From 908 Devices Inc.
Via Business Wire
Earnings Outlook For 908 Devices
Via Benzinga
908 Devices Is Well Positioned, Analyst Says While Initiating Coverage
Via Benzinga
908 Devices Launches Remote and Continuous Area Monitoring for Aerosol and Vapor Detection
From 908 Devices Inc.
Via Business Wire
908 Devices to Report Second Quarter Financial Results on August 8, 2023
From 908 Devices Inc.
Via Business Wire
908 Devices Features its High-Speed, High-Resolution Separations Technology at the 71st ASMS Conference
From 908 Devices Inc
Via Business Wire
Looking Into 908 Devices's Return On Capital Employed
Via Benzinga
12 Information Technology Stocks Moving In Tuesday's Intraday Session
Via Benzinga
908 Devices to Participate in the William Blair 43rd Annual Growth Stock Conference
From 908 Devices Inc.
Via Business Wire
908 Devices Reports First Quarter 2023 Financial Results and Reiterates 2023 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
908 Devices Launches Data Analysis Visualization Tool for REBEL At-line Cell Culture Media Analyzer
From 908 Devices Inc
Via Business Wire
Resilience Demonstrates Lower Cost of Perfusion Bioreactor Process Using 908 Devices’ REBEL At-line Analyzer
From 908 Devices Inc.
Via Business Wire
908 Devices to Report First Quarter Financial Results on May 9, 2023
From 908 Devices Inc.
Via Business Wire
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
908 Devices Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
908 Devices to Participate in the Cowen 43rd Annual Healthcare Conference
From 908 Devices Inc.
Via Business Wire
908 Devices to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
From 908 Devices Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 7, 2023
Via Benzinga
908 Devices Unveils New Glucose and Lactate On-Line Device for Bioprocess Monitoring and Control
From 908 Devices Inc.
Via Business Wire
MX908 Device Enables Correctional Facility Personnel to Quickly Identify Illegal Drugs in Incoming Mail
From 908 Devices Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
  OnFriday, 143 stocks hit new 52-week lows. 
Via Benzinga
12 Information Technology Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Information Technology Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 34 companies set new 52-week lows. 
Via Benzinga
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday. 
Via Benzinga
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.